metylperon and risperidone
metylperon has been researched along with risperidone in 6 studies
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Delius-Stute, H; Kurz, A; Rettig, K; Schwalen, S | 1 |
Buchkremer, G; Köhnke, MD; Lutz, U; Schott, K; Schwärzler, F; Weller, B; Wiatr, G | 1 |
Doblhammer, G; Eriksdotter, M; Garcia-Ptacek, S; Haenisch, B; Johnell, K; Nerius, M | 1 |
Other Studies
6 other study(ies) available for metylperon and risperidone
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently].
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antipsychotic Agents; Butyrophenones; Clinical Trials as Topic; Humans; Risperidone; Social Behavior Disorders; Treatment Outcome | 2002 |
[Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Ambulatory Care; Antipsychotic Agents; Butyrophenones; Clinical Trials as Topic; Dementia, Vascular; Dose-Response Relationship, Drug; Female; Humans; Male; Mental Disorders; Multicenter Studies as Topic; Prospective Studies; Risperidone; Treatment Outcome | 2003 |
Cytochrome P450 2D6 dependent metabolization of risperidone is inhibited by melperone.
Topics: Adult; Butyrophenones; Cytochrome P-450 CYP2D6 Inhibitors; Humans; Male; Risperidone; Schizophrenia; Sleep Deprivation | 2006 |
The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission, and Death in Dementia Patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Butyrophenones; Cohort Studies; Dementia; Female; Germany; Haloperidol; Homes for the Aged; Humans; Institutionalization; Long-Term Care; Male; Middle Aged; Nursing Homes; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone | 2018 |